Shree Hari Chemicals Export Limited announced its unaudited financial results for the quarter ended December 31, 2025, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors approved these results at their meeting held on January 31, 2026, presenting a mixed performance with revenue growth offset by declining profitability.

Financial Performance Overview

The company's standalone financial results revealed contrasting trends in revenue and profitability metrics during Q3FY26. While the top-line showed positive momentum, bottom-line performance faced significant pressure.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, the company demonstrated stronger overall performance compared to the quarterly results. Revenue from operations reached ₹14,328.94 lakhs, marking a 34.96% increase from ₹10,616.97 lakhs in the corresponding period of the previous year.

Operational Expenses and Cost Structure

The company's expense structure showed significant variations during the quarter. Total expenses increased to ₹4,333.82 lakhs from ₹3,572.10 lakhs in Q3FY25. Cost of materials consumed rose to ₹2,528.46 lakhs compared to ₹2,262.67 lakhs in the previous year. Purchase of stock-in-trade amounted to ₹3.97 lakhs during the quarter.

Employee benefit expenses increased to ₹418.80 lakhs from ₹373.67 lakhs year-on-year. Finance costs decreased to ₹55.75 lakhs from ₹60.43 lakhs, while depreciation and amortization expenses remained relatively stable at ₹55.26 lakhs.

Corporate Actions and Capital Structure

The company completed a significant corporate action during the quarter. On December 04, 2025, Shree Hari Chemicals allotted 6,05,494 equity shares upon conversion of an equal number of Zero Coupon Compulsorily Convertible Debentures (CCDs). The company had originally allotted 18,66,580 CCDs on November 15, 2024.

Regulatory Compliance and Governance

The Board of Directors approved these unaudited financial results at their meeting held on January 31, 2026, which commenced at 03:00 p.m. and concluded at 04:30 p.m. The results were reviewed by the Audit Committee and subsequently approved by the Board. Independent auditors Kailash Chand Jain & Co. conducted the limited review of both standalone and consolidated financial statements.

The company operates in a single business segment and maintains compliance with Indian Accounting Standards (Ind AS) prescribed under the Companies Act, 2013. The consolidated results, which include wholly-owned subsidiaries Shakambhari Dyechem Private Limited and Shakambhari Chemtech Private Limited, showed consolidated net profit of ₹122.10 lakhs for Q3FY26 compared to ₹262.93 lakhs in Q3FY25.

Shree hari chemicals export Limited has announced that its Board of Directors will meet on January 31, 2026, to consider and approve the company's unaudited financial results for the third quarter of fiscal year 2026. The meeting will focus on reviewing both standalone and consolidated financial statements for the quarter ended December 31, 2025.

Board Meeting Details

The company has scheduled the board meeting in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The meeting will be held on Saturday, January 31, 2026, where directors will deliberate on the quarterly financial performance.

Trading Window Closure

In accordance with the company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, Shree Hari Chemicals Export Limited has implemented a trading window closure for its securities. This measure ensures compliance with insider trading regulations during the period leading up to the financial results announcement.

Trading Window Reopening

The trading window for dealing in the company's securities will reopen 48 hours after the declaration of financial results. Based on the scheduled board meeting date, the trading window is expected to reopen on Tuesday, February 3, 2026. This timeline follows the company's established protocols and regulatory requirements for maintaining market integrity.

Regulatory Compliance

The announcement demonstrates Shree Hari Chemicals Export Limited's commitment to maintaining transparency and adhering to regulatory guidelines. The company has properly notified BSE Limited about the upcoming board meeting, ensuring all stakeholders are informed about the scheduled financial results review. The notification was signed by B.C. Agrawal, Chairman & Managing Director, on January 23, 2026.